CN105011150A - Preparation technology of seaweed healthcare oral liquid - Google Patents
Preparation technology of seaweed healthcare oral liquid Download PDFInfo
- Publication number
- CN105011150A CN105011150A CN201510529920.7A CN201510529920A CN105011150A CN 105011150 A CN105011150 A CN 105011150A CN 201510529920 A CN201510529920 A CN 201510529920A CN 105011150 A CN105011150 A CN 105011150A
- Authority
- CN
- China
- Prior art keywords
- parts
- soft
- fine
- sea
- oral liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 36
- 241001474374 Blennius Species 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000000284 extract Substances 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000002246 antineoplastic agent Substances 0.000 claims abstract description 12
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 11
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 11
- 239000005017 polysaccharide Substances 0.000 claims abstract description 11
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 10
- 150000004676 glycans Chemical class 0.000 claims abstract description 8
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 7
- 241000283690 Bos taurus Species 0.000 claims abstract description 7
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 7
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 7
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 7
- 229930006000 Sucrose Natural products 0.000 claims abstract description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 7
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 7
- 229920002678 cellulose Polymers 0.000 claims abstract description 7
- 239000001913 cellulose Substances 0.000 claims abstract description 7
- 235000012907 honey Nutrition 0.000 claims abstract description 7
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims abstract description 7
- 235000010234 sodium benzoate Nutrition 0.000 claims abstract description 7
- 239000004299 sodium benzoate Substances 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims description 26
- 239000003795 chemical substances by application Substances 0.000 claims description 21
- 150000001875 compounds Chemical class 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 15
- 238000001556 precipitation Methods 0.000 claims description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 230000003750 conditioning effect Effects 0.000 claims description 11
- 230000002155 anti-virotic effect Effects 0.000 claims description 9
- 230000003213 activating effect Effects 0.000 claims description 8
- 108010010803 Gelatin Proteins 0.000 claims description 6
- 244000241838 Lycium barbarum Species 0.000 claims description 6
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 6
- 240000007164 Salvia officinalis Species 0.000 claims description 6
- 229940006091 aloe polysaccharide Drugs 0.000 claims description 6
- 210000003056 antler Anatomy 0.000 claims description 6
- 238000004108 freeze drying Methods 0.000 claims description 6
- 229920000159 gelatin Polymers 0.000 claims description 6
- 239000008273 gelatin Substances 0.000 claims description 6
- 235000019322 gelatine Nutrition 0.000 claims description 6
- 235000011852 gelatine desserts Nutrition 0.000 claims description 6
- 238000000874 microwave-assisted extraction Methods 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 6
- 235000005412 red sage Nutrition 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 239000005720 sucrose Substances 0.000 claims description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 6
- OSELKOCHBMDKEJ-UHFFFAOYSA-N (10R)-3c-Hydroxy-10r.13c-dimethyl-17c-((R)-1-methyl-4-isopropyl-hexen-(4c)-yl)-(8cH.9tH.14tH)-Delta5-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 OSELKOCHBMDKEJ-UHFFFAOYSA-N 0.000 claims description 4
- DBTMGCOVALSLOR-DEVYUCJPSA-N (2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](CO)O[C@H](O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-DEVYUCJPSA-N 0.000 claims description 4
- CQSRUKJFZKVYCY-UHFFFAOYSA-N 5alpha-isofucostan-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 CQSRUKJFZKVYCY-UHFFFAOYSA-N 0.000 claims description 4
- 244000003416 Asparagus officinalis Species 0.000 claims description 4
- 235000005340 Asparagus officinalis Nutrition 0.000 claims description 4
- 241000258920 Chilopoda Species 0.000 claims description 4
- 241000195493 Cryptophyta Species 0.000 claims description 4
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 4
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 claims description 4
- GBBBJSKVBYJMBG-QTWVXCTBSA-N Fucosterol Natural products CC=C(CC[C@@H](C)[C@@H]1CC[C@@H]2[C@H]3C=C[C@@H]4C[C@H](O)CC[C@@]4(C)[C@@H]3CC[C@@]12C)C(C)C GBBBJSKVBYJMBG-QTWVXCTBSA-N 0.000 claims description 4
- 241000206672 Gelidium Species 0.000 claims description 4
- 240000000588 Hericium erinaceus Species 0.000 claims description 4
- 235000007328 Hericium erinaceus Nutrition 0.000 claims description 4
- OSELKOCHBMDKEJ-VRUYXKNBSA-N Isofucosterol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C OSELKOCHBMDKEJ-VRUYXKNBSA-N 0.000 claims description 4
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims description 4
- 229920001543 Laminarin Polymers 0.000 claims description 4
- 239000005717 Laminarin Substances 0.000 claims description 4
- 241000206613 Pyropia yezoensis Species 0.000 claims description 4
- 241000003864 Umbilicaria pertusa Species 0.000 claims description 4
- 235000021466 carotenoid Nutrition 0.000 claims description 4
- 150000001747 carotenoids Chemical class 0.000 claims description 4
- OSELKOCHBMDKEJ-JUGJNGJRSA-N fucosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC\C(=C/C)C(C)C)[C@@]1(C)CC2 OSELKOCHBMDKEJ-JUGJNGJRSA-N 0.000 claims description 4
- 210000003205 muscle Anatomy 0.000 claims description 4
- 241000196222 Codium fragile Species 0.000 claims description 3
- 244000252132 Pleurotus eryngii Species 0.000 claims description 3
- 235000001681 Pleurotus eryngii Nutrition 0.000 claims description 3
- 229930182558 Sterol Natural products 0.000 claims description 3
- 238000005119 centrifugation Methods 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000009833 condensation Methods 0.000 claims description 3
- 230000005494 condensation Effects 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- -1 polysaccharide sulfate Chemical class 0.000 claims description 3
- 238000002390 rotary evaporation Methods 0.000 claims description 3
- 238000007873 sieving Methods 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 150000003432 sterols Chemical class 0.000 claims description 3
- 235000003702 sterols Nutrition 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 229960003080 taurine Drugs 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 2
- 230000003612 virological effect Effects 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 abstract description 6
- 230000036039 immunity Effects 0.000 abstract description 5
- 230000003712 anti-aging effect Effects 0.000 abstract description 3
- 230000000259 anti-tumor effect Effects 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 3
- 210000004185 liver Anatomy 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 abstract 1
- 241001116389 Aloe Species 0.000 abstract 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 240000000038 Ziziphus mauritiana Species 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 235000011399 aloe vera Nutrition 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 239000008103 glucose Substances 0.000 abstract 1
- 239000003292 glue Substances 0.000 abstract 1
- 230000036737 immune function Effects 0.000 abstract 1
- 244000132619 red sage Species 0.000 abstract 1
- 229960004793 sucrose Drugs 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 description 4
- 241000756943 Codonopsis Species 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 244000119298 Emblica officinalis Species 0.000 description 2
- 235000015489 Emblica officinalis Nutrition 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses a preparation technology of a seaweed healthcare oral liquid. A mixed material comprises components in parts as follows: 25-40 parts of water, 10-15 parts of citric acid, 20-30 parts of brown sugar, 5-15 parts of cane sugar, 10-18 parts of aloe polysaccharides, 5-10 parts of edible cellulose, 5-15 parts of honey, 2-5 parts of danshen roots, 5-8 parts of peach seeds, 5-12 parts of dried longan pulp, 10-20 parts of bovine bone powder, 3-6 parts of sodium benzoate, 5-10 parts of ass hide glue, 5-10 parts of Chinese dates, 25-35 parts of a seaweed active agent, 10-25 parts of an organism regulator, 10-20 parts of an anti-tumor agent, 5-15 parts of an antiviral agent, 10-18 parts of an antioxidant and 15-30 parts of a natural alga extract. The oral liquid can enhance immunity of organisms, has effects of resisting viruses, promoting growth and the like, has higher anti-tumor activity, can regulate organism immune functions, protect livers and reduce blood fat and blood glucose and has anti-aging and anti-oxidant effects.
Description
[technical field]
The present invention relates to the technical field of health care oral liquid, particularly the technical field of the preparation technology of extra large fine and soft health care oral liquid.
[background technology]
Health care oral liquid plays the strong pharmacological action of help to many-sides such as the circulatory systems such as cardiovascular system of human body, metabolism, nervous system, make it at control various diseases, be well worth doing in health care aspect, along with the increase at age, can few weak, the lassitude of thing followed neurasthenia, insomnia and dreamful sleep, food, What is more, as suffered from coronary heart disease or having coronary heart disease to be inclined to, there are uncomfortable in chest, pectoralgia, cardio palmus shape, health care oral liquid has increases sleep, inspire enthusiasm, the merit improved a poor appetite, both can reducing blood lipid, norcholesterol, prevents and treats artery sclerosis.
[summary of the invention]
Object of the present invention solves the problems of the prior art exactly, a kind of extra large fine and soft health care oral liquid is proposed, existing health care oral liquid can be substituted, there is enhancing immunity of organisms, antiviral, the effects such as growth promoting effects, sea young pilose antler compares other sea-plants, there is larger nutritive value, collagen enriches, there is the exclusive superoxide dismutase of marine organisms and unrighted acid, there is stronger antitumor activity, can conditioner body immunity function, liver protecting, reducing blood lipid, hypoglycemic, more there is anti-ageing anti-oxidation efficacy, protection body is not by free radical damage.
For achieving the above object, the present invention proposes the preparation technology of the fine and soft health care oral liquid in a kind of sea, comprise the following steps successively:
A) compound is prepared, compound comprises following component and each component ratio is: water: 25 ~ 40 parts, citric acid: 10 ~ 15 parts, brown sugar: 20 ~ 30 parts, sucrose: 5 ~ 15 parts, aloe polysaccharide: 10 ~ 18 parts, edible cellulose: 5 ~ 10 parts, honey: 5 ~ 15 parts, the red sage root: 2 ~ 5 parts, peach kernel: 5 ~ 8 parts, arillus longan: 5 ~ 12 parts, bovine bone powder: 10 ~ 20 parts, Sodium Benzoate: 3 ~ 6 parts, donkey-hide gelatin: 5 ~ 10 parts, date: 5 ~ 10 parts, the fine and soft activating agent in sea: 25 ~ 35 parts, body conditioning agent: 10 ~ 25 parts, antitumor agent: 10 ~ 20 parts, antivirotic: 5 ~ 15 parts, antioxidant: 10 ~ 18 parts, natural seaweed extract: 15 ~ 30 parts,
B) first compound is added in high speed disintegrator, High Rotation Speed is pulverized, again powder is entered in homogenizer, even compacting, process 1.5 ~ 3h, the standard of sieving is 20 orders and 8 orders, then the compound after process is added water and 1% pectase of 200ml, according to the solid-to-liquid ratio of 1:20, water-bath lixiviate in the hot water of 40 DEG C, extraction time is 1.5h;
C) compound after b) step process is added in Microwave Extraction device again, according to solid-to-liquid ratio 20:1,1% pectase, extracts 30min, repeatedly extract 3 times, Microwave Extraction temperature is 80 DEG C, adds 80 ~ 100 parts of water simultaneously, is mixed into together in compound, uniform stirring 1h, again material liquid is carried out filter centrifugation, centrifugal rotational speed is 10000r/min, centrifugal 10min;
D) supernatant is put into Rotary Evaporators, rotary evaporation concentrates, and the liquid after concentrated carries out constant volume, and constant volume is to 250ml, then classification alcohol precipitation, the first alcohol precipitation concentration is the 30%, second alcohol precipitation concentration is 60%, 3rd alcohol precipitation concentration is 80%, then centrifuging and taking precipitation, then freeze drying.Freeze drying temperature controls, at-5 DEG C, in condensation process, to obtain algal polysaccharides, is finished product after the basal nutrient bases such as mixing red date, matrimony vine, brown sugar;
E) by through steps d) finished product after process first carries out liquid high-temperature sterilization, carries out hot filling, then manages bottle, suppresses, sterilizing etc., carries out wash bottle label;
As preferably, the fine and soft activating agent in described sea is made up of sea young pilose antler, extra large fine and soft core, extra large fine and soft tail, extra large fine and soft muscle, and described sea young pilose antler, extra large fine and soft core, extra large fine and soft tail, extra large fine and soft muscle mix according to the ratio uniform of 2:1:1:1.
As preferably, described body conditioning agent is obtained by several mixing any in carotenoid, taurine, sterol, fucosterol.
As preferably, described antitumor agent is obtained by several mixing any in Porphyra yezoensis, matrimony vine, pleurotus eryngii, Hericium erinaceus.
As preferably, described viral agent is obtained by several mixing any in laminarin, polysaccharide sulfate, fucose, divaricate gelidium thallus polysaccharide.
As preferably, described natural seaweed extract comprises any several mixing in U. pertusa, Codiumfragile(sur.) Hariot., Heng Shi gulfweed, asparagus, centipede algae and obtains.
Beneficial effect of the present invention: the present invention can have enhancing immunity of organisms, antiviral, the effects such as growth promoting effects, sea young pilose antler compares other sea-plants, there is larger nutritive value, collagen enriches, there is the exclusive superoxide dismutase of marine organisms and unrighted acid, there is stronger antitumor activity, can conditioner body immunity function, liver protecting, reducing blood lipid, hypoglycemic, more there is anti-ageing anti-oxidation efficacy, protection body is not by free radical damage, increase sleep, inspire enthusiasm, the merit improved a poor appetite, both can reducing blood lipid, norcholesterol, prevent and treat artery sclerosis.
[detailed description of the invention]
A preparation technology for the fine and soft health care oral liquid in sea, comprises the following steps successively:
A) compound is prepared, compound comprises following component and each component ratio is: water: 25 ~ 40 parts, citric acid: 10 ~ 15 parts, brown sugar: 20 ~ 30 parts, sucrose: 5 ~ 15 parts, aloe polysaccharide: 10 ~ 18 parts, edible cellulose: 5 ~ 10 parts, honey: 5 ~ 15 parts, the red sage root: 2 ~ 5 parts, peach kernel: 5 ~ 8 parts, arillus longan: 5 ~ 12 parts, bovine bone powder: 10 ~ 20 parts, Sodium Benzoate: 3 ~ 6 parts, donkey-hide gelatin: 5 ~ 10 parts, date: 5 ~ 10 parts, the fine and soft activating agent in sea: 25 ~ 35 parts, body conditioning agent: 10 ~ 25 parts, antitumor agent: 10 ~ 20 parts, antivirotic: 5 ~ 15 parts, antioxidant: 10 ~ 18 parts, natural seaweed extract: 15 ~ 30 parts,
B) first compound is added in high speed disintegrator, High Rotation Speed is pulverized, again powder is entered in homogenizer, even compacting, process 1.5 ~ 3h, the standard of sieving is 20 orders and 8 orders, then the compound after process is added water and 1% pectase of 200ml, according to the solid-to-liquid ratio of 1:20, water-bath lixiviate in the hot water of 40 DEG C, extraction time is 1.5h;
C) compound after b) step process is added in Microwave Extraction device again, according to solid-to-liquid ratio 20:1,1% pectase, extracts 30min, repeatedly extract 3 times, Microwave Extraction temperature is 80 DEG C, adds 80 ~ 100 parts of water simultaneously, is mixed into together in compound, uniform stirring 1h, again material liquid is carried out filter centrifugation, centrifugal rotational speed is 10000r/min, centrifugal 10min;
D) supernatant is put into Rotary Evaporators, rotary evaporation concentrates, and the liquid after concentrated carries out constant volume, and constant volume is to 250ml, then classification alcohol precipitation, the first alcohol precipitation concentration is the 30%, second alcohol precipitation concentration is 60%, 3rd alcohol precipitation concentration is 80%, then centrifuging and taking precipitation, then freeze drying.Freeze drying temperature controls, at-5 DEG C, in condensation process, to obtain algal polysaccharides, is finished product after the basal nutrient bases such as mixing red date, matrimony vine, brown sugar;
E) by through steps d) finished product after process first carries out liquid high-temperature sterilization, carries out hot filling, then manages bottle, suppresses, sterilizing etc., carries out wash bottle label.
Embodiment one:
A kind of extra large fine and soft health care oral liquid, comprise following component and the ratio of each component is: water: 25 parts, citric acid: 10 parts, brown sugar: 20 parts, sucrose: 5 parts, aloe polysaccharide: 10 parts, edible cellulose: 5 parts, honey: 5 parts, the red sage root: 2 parts, peach kernel: 5 parts, arillus longan: 5 parts, bovine bone powder: 10 parts, Sodium Benzoate: 3 parts, donkey-hide gelatin: 5 parts, date: 5 parts, the fine and soft activating agent in sea: 25 parts, body conditioning agent: 10 parts, antitumor agent: 10 parts, antivirotic: 5 parts, antioxidant: 10 parts, natural seaweed extract: 15 parts, body conditioning agent is by carotenoid, taurine mixing is obtained, antitumor agent is by Porphyra yezoensis, matrimony vine mixing is obtained, antivirotic is by laminarin, polysaccharide sulfate, fucose mixing is obtained, antioxidant is by phyllanthus emblica, white fungus, fructus schisandrae mixing is obtained, natural seaweed extract comprises U. pertusa, Codiumfragile(sur.) Hariot., the mixing of Heng Shi gulfweed is obtained.
Embodiment two:
A kind of extra large fine and soft health care oral liquid, comprise following component and the ratio of each component is: water: 30 parts, citric acid: 13 parts, brown sugar: 23 parts, sucrose: 12 parts, aloe polysaccharide: 15 parts, edible cellulose: 8 parts, honey: 11 parts, the red sage root: 3 parts, peach kernel: 7 parts, arillus longan: 11 parts, bovine bone powder: 14 parts, Sodium Benzoate: 4 parts, donkey-hide gelatin: 8 parts, date: 8 parts, the fine and soft activating agent in sea: 30 parts, body conditioning agent: 20 parts, antitumor agent: 15 parts, antivirotic: 10 parts, antioxidant: 15 parts, natural seaweed extract: 24 parts, body conditioning agent is by carotenoid, fucosterol mixing is obtained, antitumor agent is by Porphyra yezoensis, Hericium erinaceus mixing is obtained, antivirotic is by laminarin, the mixing of divaricate gelidium thallus polysaccharide is obtained, antioxidant is by phyllanthus emblica, white fungus, Radix Codonopsis mixing is obtained, natural seaweed extract comprises U. pertusa, asparagus, the mixing of centipede algae is obtained.
Embodiment three:
A kind of extra large fine and soft health care oral liquid, comprise following component and the ratio of each component is: water: 40 parts, citric acid: 15 parts, brown sugar: 30 parts, sucrose: 15 parts, aloe polysaccharide: 18 parts, edible cellulose: 10 parts, honey: 15 parts, the red sage root: 5 parts, peach kernel: 8 parts, arillus longan: 12 parts, bovine bone powder: 20 parts, Sodium Benzoate: 6 parts, donkey-hide gelatin: 10 parts, date: 10 parts, the fine and soft activating agent in sea: 35 parts, body conditioning agent: 25 parts, antitumor agent: 20 parts, antivirotic: 15 parts, antioxidant: 18 parts, natural seaweed extract: 30 parts, body conditioning agent is by sterol, fucosterol mixing is obtained, antitumor agent is by pleurotus eryngii, Hericium erinaceus mixing is obtained, antivirotic is by fucose, the mixing of divaricate gelidium thallus polysaccharide is obtained, antioxidant is by fructus schisandrae, the Radix Astragali, Radix Codonopsis mixing is obtained, natural seaweed extract comprises Heng Shi gulfweed, asparagus, the mixing of centipede algae is obtained.
Above-described embodiment is to explanation of the present invention, is not limitation of the invention, anyly all belongs to protection scope of the present invention to the scheme after simple transformation of the present invention.
Claims (6)
1. a preparation technology for the fine and soft health care oral liquid in sea, comprises the following steps successively:
A) compound is prepared, compound comprises following component and each component ratio is: water: 25 ~ 40 parts, citric acid: 10 ~ 15 parts, brown sugar: 20 ~ 30 parts, sucrose: 5 ~ 15 parts, aloe polysaccharide: 10 ~ 18 parts, edible cellulose: 5 ~ 10 parts, honey: 5 ~ 15 parts, the red sage root: 2 ~ 5 parts, peach kernel: 5 ~ 8 parts, arillus longan: 5 ~ 12 parts, bovine bone powder: 10 ~ 20 parts, Sodium Benzoate: 3 ~ 6 parts, donkey-hide gelatin: 5 ~ 10 parts, date: 5 ~ 10 parts, the fine and soft activating agent in sea: 25 ~ 35 parts, body conditioning agent: 10 ~ 25 parts, antitumor agent: 10 ~ 20 parts, antivirotic: 5 ~ 15 parts, antioxidant: 10 ~ 18 parts, natural seaweed extract: 15 ~ 30 parts,
B) first compound is added in high speed disintegrator, High Rotation Speed is pulverized, again powder is entered in homogenizer, even compacting, process 1.5 ~ 3h, the standard of sieving is 20 orders and 8 orders, then the compound after process is added water and 1% pectase of 200ml, according to the solid-to-liquid ratio of 1:20, water-bath lixiviate in the hot water of 40 DEG C, extraction time is 1.5h;
C) compound after b) step process is added in Microwave Extraction device again, according to solid-to-liquid ratio 20:1,1% pectase, extracts 30min, repeatedly extract 3 times, Microwave Extraction temperature is 80 DEG C, adds 80 ~ 100 parts of water simultaneously, is mixed into together in compound, uniform stirring 1h, again material liquid is carried out filter centrifugation, centrifugal rotational speed is 10000r/min, centrifugal 10min;
D) supernatant is put into Rotary Evaporators, rotary evaporation concentrates, and the liquid after concentrated carries out constant volume, and constant volume is to 250ml, then classification alcohol precipitation, the first alcohol precipitation concentration is the 30%, second alcohol precipitation concentration is 60%, 3rd alcohol precipitation concentration is 80%, then centrifuging and taking precipitation, then freeze drying.Freeze drying temperature controls, at-5 DEG C, in condensation process, to obtain algal polysaccharides, is finished product after the basal nutrient bases such as mixing red date, matrimony vine, brown sugar;
E) by through steps d) finished product after process first carries out liquid high-temperature sterilization, carries out hot filling, then manages bottle, suppresses, sterilizing etc., carries out wash bottle label.
2. the preparation technology of the fine and soft health care oral liquid in a kind of sea as claimed in claim 1, it is characterized in that: the fine and soft activating agent in described sea is made up of sea young pilose antler, extra large fine and soft core, extra large fine and soft tail, extra large fine and soft muscle, and described sea young pilose antler, extra large fine and soft core, extra large fine and soft tail, extra large fine and soft muscle mix according to the ratio uniform of 2:1:1:1.
3. the preparation technology of the fine and soft health care oral liquid in a kind of sea as claimed in claim 1, is characterized in that: body conditioning agent is obtained by several mixing any in carotenoid, taurine, sterol, fucosterol.
4. the preparation technology of the fine and soft health care oral liquid in a kind of sea as claimed in claim 1, is characterized in that: antitumor agent is obtained by several mixing any in Porphyra yezoensis, matrimony vine, pleurotus eryngii, Hericium erinaceus.
5. the preparation technology of the fine and soft health care oral liquid in a kind of sea as claimed in claim 1, is characterized in that: viral agent is obtained by several mixing any in laminarin, polysaccharide sulfate, fucose, divaricate gelidium thallus polysaccharide.
6. the preparation technology of the fine and soft health care oral liquid in a kind of sea as claimed in claim 1, is characterized in that: natural seaweed extract comprises any several mixing in U. pertusa, Codiumfragile(sur.) Hariot., Heng Shi gulfweed, asparagus, centipede algae and obtains.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510529920.7A CN105011150A (en) | 2015-08-26 | 2015-08-26 | Preparation technology of seaweed healthcare oral liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510529920.7A CN105011150A (en) | 2015-08-26 | 2015-08-26 | Preparation technology of seaweed healthcare oral liquid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105011150A true CN105011150A (en) | 2015-11-04 |
Family
ID=54401758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510529920.7A Pending CN105011150A (en) | 2015-08-26 | 2015-08-26 | Preparation technology of seaweed healthcare oral liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105011150A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107334037A (en) * | 2017-08-10 | 2017-11-10 | 合肥元政农林生态科技有限公司 | A kind of preparation method of antiviral common vetch dish oral liquid |
| CN109077323A (en) * | 2018-08-31 | 2018-12-25 | 青岛海洋生物医药研究院股份有限公司 | A kind of Antarctic Ocean young pilose antler polysaccharide composition and preparation method thereof |
| WO2019218094A1 (en) * | 2018-05-16 | 2019-11-21 | Saa Lisboa Luis | Sauces based on algae and molluscs |
| CN113476485A (en) * | 2021-07-30 | 2021-10-08 | 珠海中科先进技术研究院有限公司 | Preparation method and application of hypsizigus marmoreus extracting solution |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1322497A (en) * | 2001-02-16 | 2001-11-21 | 北京博泰迪生物工程科技开发有限公司 | Oral liquid of marine organism and its preparation |
| CN101361774A (en) * | 2008-09-01 | 2009-02-11 | 北京世纪博康医药科技有限公司 | Combination containing brown alga polysaccharide sulfuric ester and panax ginseng and use thereof |
| CN101845102A (en) * | 2010-06-22 | 2010-09-29 | 中国烟草总公司郑州烟草研究院 | Preparation of asparagus rough polysaccharide and application thereof in cigarette |
| CN104068302A (en) * | 2013-03-29 | 2014-10-01 | 烟台大学 | Enteromorpha polysaccharide oral liquid and preparation method thereof |
| CN104171771A (en) * | 2014-07-04 | 2014-12-03 | 颜贤鹏 | Processing method of sargassum fusiforme oral liquid |
-
2015
- 2015-08-26 CN CN201510529920.7A patent/CN105011150A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1322497A (en) * | 2001-02-16 | 2001-11-21 | 北京博泰迪生物工程科技开发有限公司 | Oral liquid of marine organism and its preparation |
| CN101361774A (en) * | 2008-09-01 | 2009-02-11 | 北京世纪博康医药科技有限公司 | Combination containing brown alga polysaccharide sulfuric ester and panax ginseng and use thereof |
| CN101845102A (en) * | 2010-06-22 | 2010-09-29 | 中国烟草总公司郑州烟草研究院 | Preparation of asparagus rough polysaccharide and application thereof in cigarette |
| CN104068302A (en) * | 2013-03-29 | 2014-10-01 | 烟台大学 | Enteromorpha polysaccharide oral liquid and preparation method thereof |
| CN104171771A (en) * | 2014-07-04 | 2014-12-03 | 颜贤鹏 | Processing method of sargassum fusiforme oral liquid |
Non-Patent Citations (2)
| Title |
|---|
| 余华等: "三种海带多糖粗品提取条件的研究", 《食品工业科技》 * |
| 高梦祥等: "采用微波技术提取海带多糖的工艺研究", 《食品研究与开发》 * |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107334037A (en) * | 2017-08-10 | 2017-11-10 | 合肥元政农林生态科技有限公司 | A kind of preparation method of antiviral common vetch dish oral liquid |
| WO2019218094A1 (en) * | 2018-05-16 | 2019-11-21 | Saa Lisboa Luis | Sauces based on algae and molluscs |
| CN109077323A (en) * | 2018-08-31 | 2018-12-25 | 青岛海洋生物医药研究院股份有限公司 | A kind of Antarctic Ocean young pilose antler polysaccharide composition and preparation method thereof |
| CN113476485A (en) * | 2021-07-30 | 2021-10-08 | 珠海中科先进技术研究院有限公司 | Preparation method and application of hypsizigus marmoreus extracting solution |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104856035A (en) | Health-care product for recuperating specific intrinsic constitution | |
| CN106942542A (en) | A kind of cubilose beverage of the grain of suspension containing nostoc and preparation method thereof | |
| CN105011150A (en) | Preparation technology of seaweed healthcare oral liquid | |
| CN107586672A (en) | A kind of Rosa roxburghii health liquor and preparation method thereof | |
| CN105231352A (en) | Health-care lotus root starch and preparation method thereof | |
| CN105384562A (en) | Pleurotus geesteranus medium | |
| CN105031315A (en) | Ocean health care capsule having efficacy of lowering blood sugar | |
| CN104187953B (en) | Fructus Rhodomyrti beverage | |
| CN104171240A (en) | Preserved mioga ginger and honeysuckle | |
| CN104877882A (en) | Astaxanthin composite mixed liquor with blood glucose reducing function | |
| CN104522287A (en) | Preparation method and application of giant salamander albumen powder | |
| CN106819280A (en) | Health tea formula prepared by a kind of use Tongkat Ali, Momordica grosvenori | |
| CN105231354A (en) | Lotus root starch capable of nourishing faces and preparation method of lotus root starch | |
| CN104984102A (en) | Astaxanthin health care capsule with blood sugar decreasing effect | |
| CN111227143A (en) | Sparassis crispa health-care beverage and preparation method thereof | |
| CN106306859A (en) | Pepper and ginger silky fowl soup and preparation method thereof | |
| CN109275744A (en) | A kind of red bean milk tea | |
| CN103989097B (en) | A kind of honeydew tongue of blueberry flavor does and processing method | |
| CN108576792A (en) | A kind of diet and preparation method thereof of compound chitosan oligosaccharide conditioning cancer | |
| CN107927401A (en) | A kind of Chinese herbal feed additive for being used to promote piglet to grow and preparation method thereof | |
| CN108783354A (en) | A kind of adlay beauty and health care soup and preparation method thereof | |
| CN108041422A (en) | A kind of health bamboo wine rice powder and preparation method thereof | |
| CN107935979A (en) | The method that anthocyanidin is extracted from pitaya peel | |
| CN107348082A (en) | A kind of Rosa roxburghii scented tea and preparation method thereof | |
| CN106307537A (en) | Rosa roxburghii tratt oral liquid and production technology thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20151104 |